Related Experiment Video

Updated: Jun 13, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

The anticancer activity of 3- and 10-bromofascaplysins is mediated by caspase-8, -9, -3-dependent apoptosis

Alexandra S Kuzmich1, Sergey N Fedorov, Valeria V Shastina

  • 1Pacific Institute of Bioorganic Chemistry, 159 Prospect 100-Let Vladivostoku, Vladivostok 690022, Russian Federation.

Bioorganic & Medicinal Chemistry
|May 12, 2010
PubMed

Insights

3- and 10-Bromofascaplysins demonstrate potent anticancer effects by inducing apoptosis in various cancer cell lines. These compounds show promise as cancer-preventive agents, acting at submicromolar concentrations.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • 3- and 10-Bromofascaplysins are known for their cytotoxic activity.
  • Previous research indicated their potential, necessitating further investigation into their anticancer mechanisms.

Purpose of the Study:

  • To investigate the cancer preventive and proapoptotic properties of 3- and 10-Bromofascaplysins.
  • To evaluate the efficacy of these compounds in various human and mouse cancer cell lines.

Main Methods:

  • Cell viability (MTS) assay
  • Flow cytometry
  • Anchorage-independent soft agar assay
  • Luciferase assay
  • Mitochondrial permeability assay
  • Western blotting

Main Results:

  • 3- and 10-Bromofascaplysins exhibited significant anticancer effects at submicromolar concentrations.
  • Apoptosis was induced in cancer cells, evidenced by the activation of caspase-8, -9, and -3.
  • The compounds demonstrated efficacy across multiple cancer cell lines, including HL-60, THP-1, SNU-C4, SK-MEL-28, DLD-1, MDA-MB-231, and HeLa cells.

Conclusions:

  • 3- and 10-Bromofascaplysins possess significant cancer preventive and proapoptotic properties.
  • Their mechanism of action involves the induction of caspase-dependent apoptosis.
  • These compounds represent promising candidates for anticancer drug development.

More Related Videos

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry05:29

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry

Published on: March 24, 2023

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...